{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:56:09Z","timestamp":1780566969775,"version":"3.54.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>We present the histopathology of 12 skin biopsies from 6 patients with vacuoles, enzyme E1, X-linked, autoinflammatory, somatic syndrome and review the literature. The age of these 6 men ranges from 62 to 83 years (median of 70 years). <jats:italic toggle=\"yes\">UBA1<\/jats:italic> mutation was documented in all 6 patients. Multiple organ systems were involved with constitutional symptoms noted in 4 of 6 patients (67%), cutaneous involvement in 6 of 6 patients (100%), hematologic abnormalities in 6 of 6 patients (100%), pulmonary involvement in 4 of 6 patients (67%), musculoskeletal abnormalities in 3 of 6 patients (50%), vascular thrombosis in 2 of 6 patients (33%), ocular involvement in 2 of 6 patients (33%), and gastrointestinal involvement in 5 of 6 patients (83%). Of the 6 presented patients, neutrophilic dermatosis was seen in 3 biopsies, histiocytoid neutrophilic dermatosis in 1 biopsy, neutrophilic dermatosis with vasculitis in 1 biopsy, neutrophilic and granulomatous dermatitis in 2 biopsies, septal panniculitis consistent with erythema nodosum in 2 biopsies, and nonspecific patterns in 3 biopsies. In summary, neutrophilic dermatosis, small-vessel vasculitis, and panniculitis are frequent histopathologic patterns noted in decreasing frequency in skin biopsies of the patients with vacuoles, enzyme E1, X-linked, autoinflammatory, somatic syndrome. However, the histopathologic findings can be diverse, nonspecific in some instances, and varied among different biopsies obtained from the same patient.<\/jats:p>","DOI":"10.1097\/dad.0000000000002716","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:39Z","timestamp":1726704039000},"page":"637-647","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Histopathology of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic Syndrome: Report of 12 Skin Biopsies From 6 Patients"],"prefix":"10.1097","volume":"46","author":[{"given":"Bethany J.","family":"Brumbaugh","sequence":"first","affiliation":[{"name":"Medical Student, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro C.","family":"Laga","sequence":"additional","affiliation":[{"name":"Associate Professor of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Pouli","sequence":"additional","affiliation":[{"name":"Clinical Fellow of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Fernandez-Figueras","sequence":"additional","affiliation":[{"name":"Associate Professor of Pathology, Hospital Universitari General de Catalunya, Grupo Quironsalud, Barcelona, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[{"name":"Professor of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","article-title":"VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)","volume":"107","author":"Stubbins","year":"2021","journal-title":"Haematologica"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/ijd.16635","article-title":"Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings","volume":"62","author":"Hines","year":"2023","journal-title":"Int J Dermatol"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large\u2010scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin\u2010Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"key":"R6-20250616","first-page":"9414","article-title":"VEXAS syndrome with cutaneous nodules","volume":"14","author":"Argobi","year":"2022","journal-title":"Dermatol Rep"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ajd.13932","article-title":"VEXAS syndrome: a dermatological perspective","volume":"63","author":"Nguyen","year":"2022","journal-title":"Australas J Dermatol"},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"1046820","DOI":"10.3389\/fmed.2022.1046820","article-title":"A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment","volume":"9","author":"Tozaki","year":"2022","journal-title":"Front Med"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00296-022-05266-2","article-title":"Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review","volume":"43","author":"Kouranloo","year":"2023","journal-title":"Rheumatol Int"},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS","volume":"149","author":"van der Made","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11239-021-02608-y","article-title":"Thrombosis in VEXAS syndrome","volume":"53","author":"Oo","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"R12-20250616","first-page":"244","article-title":"Spectrum of clonal hematopoiesis in VEXAS syndrome","volume":"142","author":"Gutierrez-Rodrigues","year":"2023","journal-title":"Blood"},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s10067-022-06338-1","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review","volume":"41","author":"Guerrero-Berm\u00fadez","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/rheumatology\/kead240","article-title":"How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies","volume":"62","author":"Boyadzhieva","year":"2023","journal-title":"Rheumatology"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2022.01.042","article-title":"VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist","volume":"89","author":"Sterling","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"1071983","DOI":"10.3389\/fimmu.2023.1071983","article-title":"Cutaneous manifestations associated with immune checkpoint inhibitors","volume":"14","author":"Watanabe","year":"2023","journal-title":"Front Immunol"},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40164-022-00262-5","article-title":"Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome","volume":"11","author":"Lacombe","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2022.10.052","article-title":"Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases","volume":"88","author":"Zakine","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.41957","article-title":"VEXAS syndrome with systemic lupus erythematosus- expanding the spectrum of associated conditions","volume":"74","author":"Sharma","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/ijd.15916","article-title":"Atypical extensive lupus tumidus-like eruption as an early presentation of VEXAS syndrome","volume":"61","author":"Ribereau-Gayon","year":"2022","journal-title":"Int J Dermatol"},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/ard-2023-224460","article-title":"Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism","volume":"82","author":"Mascaro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7326\/L21-0023","article-title":"Severe joint involvement in VEXAS syndrome: a case report","volume":"174","author":"Lacombe","year":"2021","journal-title":"Ann Intern Med"},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1093\/rheumatology\/keab349","article-title":"A case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years","volume":"60","author":"Sakuma","year":"2021","journal-title":"Rheumatology"},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdcr.2021.06.010","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndrome","volume":"14","author":"Alhomida","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/art.42257","article-title":"Clinical images: VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa","volume":"74","author":"Itagane","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R26-20250616","first-page":"002484","article-title":"The VEXAS syndrome: uncontrolled inflammation and macrocytic anaemia in a 77-year-old male patient","volume":"8","author":"Himmelmann","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1111\/ijd.16132","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a presentation of two cases with dermatologic findings","volume":"62","author":"Mohammed","year":"2023","journal-title":"Int J Dermatol"},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.41992","article-title":"VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis","volume":"74","author":"Muratore","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/rheumatology\/keab782","article-title":"VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis","volume":"61","author":"Pamies","year":"2022","journal-title":"Rheumatology"},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/15353702231165030","article-title":"JAK inhibitors for the treatment of VEXAS syndrome","volume":"248","author":"Bindoli","year":"2023","journal-title":"Exp Biol Med"},{"key":"R31-20250616","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/imj.85_15894","article-title":"P86: vexas syndrome: a case of treatment refractory, severe autoinflammatory disease","volume":"52","author":"Habershon","year":"2022","journal-title":"Intern Med J"},{"key":"R32-20250616","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.mayocp.2021.06.006","article-title":"Clinical heterogeneity of the VEXAS syndrome: a case series","volume":"96","author":"Koster","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R33-20250616","first-page":"e39906","article-title":"A case of VEXAS: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome with co-existing DNA (Cytosine-5)-methyltransferase 3A mutation complicated by localized skin reaction to tocilizumab and azacitidine","volume":"15","author":"Estes","year":"2023","journal-title":"Cureus"},{"key":"R34-20250616","doi-asserted-by":"crossref","first-page":"678927","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"key":"R35-20250616","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/art.41775","article-title":"Extensive multiple organ involvement in VEXAS syndrome","volume":"73","author":"Takahashi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R36-20250616","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/imj.15742","article-title":"VEXAS syndrome: lessons learnt from an early Australian case series","volume":"52","author":"Islam","year":"2022","journal-title":"Intern Med J"},{"key":"R37-20250616","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00403-022-02340-4","article-title":"VEXAS syndrome in dermatology","volume":"315","author":"Afsahi","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R38-20250616","doi-asserted-by":"crossref","first-page":"102636","DOI":"10.1016\/j.bcmd.2021.102636","article-title":"A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis","volume":"93","author":"Kao","year":"2022","journal-title":"Blood Cells Mol Dis"},{"key":"R39-20250616","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jdcr.2023.06.021","article-title":"VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib","volume":"38","author":"Fahmy","year":"2023","journal-title":"JAAD Case Rep"},{"key":"R40-20250616","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41409-021-01544-y","article-title":"Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report","volume":"57","author":"Loschi","year":"2022","journal-title":"Bone Marrow Transpl"},{"key":"R41-20250616","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1093\/rheumatology\/keab225","article-title":"VEXAS syndrome: still expanding the clinical phenotype","volume":"60","author":"Oganesyan","year":"2021","journal-title":"Rheumatology"},{"key":"R42-20250616","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/art.42471","article-title":"Novel somatic UBA1 variant in a patient with VEXAS syndrome","volume":"75","author":"Stiburkova","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R43-20250616","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 Variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R44-20250616","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MD.0b013e3181943f5e","article-title":"Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature","volume":"88","author":"Kieffer","year":"2009","journal-title":"Medicine"},{"key":"R45-20250616","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.3390\/ijms21218090","article-title":"Importance of deubiquitination in macrophage-mediated viral response and inflammation","volume":"21","author":"Rasaei","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R46-20250616","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.17930","article-title":"Towards treatments for VEXAS","volume":"196","author":"Patel","year":"2022","journal-title":"Br J Haematol"},{"key":"R47-20250616","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2021.09.001","article-title":"Toward a pathophysiology inspired treatment of VEXAS syndrome","volume":"58","author":"Heiblig","year":"2021","journal-title":"Semin Hematol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:01:07Z","timestamp":1750096867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002716","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}